Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc.

6.15
EUR
-0.59
(-8.75%)
-3.65EPS
858.05MMarket Cap
Nov 05Next Earn

Latest Stock Split

Jan 02, 2024

1:240

For every 240 shares held, investors received 1. The price per share adjusted from $0.00 to $0.04.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jan 02, 2024
    Before$0.00
    Split ratio1:240
    After$0.04
    Reverse
  2. Jul 08, 2022
    Before—
    Split ratio1:12
    After—
    Reverse

About Avalo Therapeutics, Inc. stock splits

Avalo Therapeutics, Inc. (GETTEX:C6K0) operates in the Pharmaceuticals: major industry.

Avalo Therapeutics, Inc. company overview

When did Avalo Therapeutics, Inc. stock split?

Avalo Therapeutics, Inc.'s most recent stock split was on January 2, 2024. It was a 1-for-240 reverse split, so shareholders received 1 share for every 240 they held.

What is Avalo Therapeutics, Inc.'s stock split history?

Avalo Therapeutics, Inc. (GETTEX:C6K0) has split its stock 2 times: a 1-for-12 reverse split on July 8, 2022 and a 1-for-240 reverse split on January 2, 2024.

How many times has Avalo Therapeutics, Inc. stock split?

Avalo Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between July 8, 2022 and January 2, 2024.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Avalo Therapeutics, Inc.'s 1-for-240 reverse split on January 2, 2024, every 240 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Avalo Therapeutics, Inc. split its stock again?

Avalo Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on January 2, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:C6K0 split will appear on this page.